Skip to content

Amphastar Pharmaceuticals

US · AMPH #3194 by market cap
25.54 -0.37 -1.43%
Live - 5344 symbols - heartbeat 34s ago · 2026-10-08 08:29
Pre-market 25.54 0.00%
After-hours 25.54 0.00%
Market cap
1.09B
P/B
1.41
EPS
2.03
Reader sentiment Are you bullish or bearish on AMPH?

Anonymous reader poll. Unscientific, not investment advice.

About Amphastar Pharmaceuticals

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredients. It operates through Pharmaceutical Products segment. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.

Founded
1996
CEO
Dr. Jack Yongfeng Zhang, PhD
Employees
1,976
Headquarters
Rancho Cucamonga, California, United States of America
Fiscal year end
12-31
Website
amphastar.com

Company profile

Exchange
US
Symbol
AMPH
Market-cap rank
#3194
Market cap
1.09B
Float cap
799.22M
Shares out
42.54M
Float shares
31.29M

Sectors & themes

Drug Manufacturers - Specialty & Generic Cannabis & Hemp Global medical industry Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 08:29:55 · For reference only, not investment advice and not tailored to your situation.